- Home
- DRDB vs PACB Comparison
DRDB vs PACB Comparison
Compare DRDB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRDB
- PACB
- Stock Information
- Founded
- DRDB 2024
- PACB 2000
- Country
- DRDB United States
- PACB United States
- Employees
- DRDB N/A
- PACB N/A
- Industry
- DRDB
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- DRDB
- PACB Industrials
- Exchange
- DRDB Nasdaq
- PACB Nasdaq
- Market Cap
- DRDB 308.5M
- PACB 364.2M
- IPO Year
- DRDB 2024
- PACB 2010
- Fundamental
- Price
- DRDB $10.00
- PACB $1.17
- Analyst Decision
- DRDB
- PACB Buy
- Analyst Count
- DRDB 0
- PACB 13
- Target Price
- DRDB N/A
- PACB $2.46
- AVG Volume (30 Days)
- DRDB 135.4K
- PACB 8.7M
- Earning Date
- DRDB 01-01-0001
- PACB 05-08-2025
- Dividend Yield
- DRDB N/A
- PACB N/A
- EPS Growth
- DRDB N/A
- PACB N/A
- EPS
- DRDB N/A
- PACB N/A
- Revenue
- DRDB N/A
- PACB $154,014,000.00
- Revenue This Year
- DRDB N/A
- PACB $6.51
- Revenue Next Year
- DRDB N/A
- PACB $23.76
- P/E Ratio
- DRDB $571.81
- PACB N/A
- Revenue Growth
- DRDB N/A
- PACB N/A
- 52 Week Low
- DRDB $9.87
- PACB $1.08
- 52 Week High
- DRDB $10.06
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- DRDB N/A
- PACB 42.80
- Support Level
- DRDB N/A
- PACB $1.27
- Resistance Level
- DRDB N/A
- PACB $1.49
- Average True Range (ATR)
- DRDB 0.00
- PACB 0.13
- MACD
- DRDB 0.00
- PACB 0.00
- Stochastic Oscillator
- DRDB 0.00
- PACB 21.95
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.